Feb. 21, 2024
by BiopharmaTrend
News
Insilico Medicine, a leader in AI-driven drug discovery, has developed a new preclinical candidate, ISM9682, aimed at treating advanced solid …
Feb. 21, 2024
by BiopharmaTrend
News
Absci has embarked on IND-enabling studies for ABS-101, an anti-TL1A antibody, leveraging its generative AI technology to streamline the development …
Jan. 12, 2024
by Andrii Buvailo
News
Verge Genomics, a clinical-stage biotechnology company, has just initiated a Phase 1b proof-of-concept study for VRG50635, a drug developed for …
Dec. 26, 2023
by Andrii Buvailo
Biopharma insight
In the current climate of global economic uncertainty, one area of pharmaceutical development is bucking the trend with a significant …
Sept. 3, 2023
by Andrii Buvailo
Interview
In August, AbbVie has secured European Commission (EC) approval for AQUIPTA® (atogepant) as a preventive treatment for adults experiencing four …
July 14, 2023
by Andrii Buvailo
Biopharma insight
Since the early days of the pharmaceutical industry, small molecules have been the most extensively used group of drugs. Nowadays, …
June 20, 2023
by Irina Bilous
Biopharma insight
Verge Genomics, a frontrunner in the implementation of AI in drug discovery, recently concluded the Phase 1 clinical trial of …
June 7, 2023
by Bohdana Sokolova
Biopharma insight
Incorporating AI in drug discovery is rapidly becoming a common practice in the pharmaceutical industry. The recent undertakings of UK-based …
May 31, 2023
by Illia Petrov
Biopharma insight
In an essential leap forward for the utilization of artificial intelligence (AI) in drug discovery, Insilico Medicine secured Investigational New …
May 23, 2023
by Irina Bilous
Biopharma insight
Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …
May 22, 2023
by Irina Bilous
Biopharma insight
PharmEnable, an innovative drug discovery firm, recently secured $7.5M in Pre-Series A financing, reflecting growing confidence in its proprietary AI-based …
April 20, 2023
by Illia Petrov
Biopharma insight
Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …